Wyeth and Mochida end analgesic tie-up
This article was originally published in Scrip
Executive Summary
Wyeth (Pfizer) and Mochida Pharmaceutical have ended a licensing deal for a novel class of pain treatments discovered by the mid-sized Japanese firm.